Suchergebnisse - "Uchino, Junji"

PubPharm (13)

1

Prophylactic treatment of dacomitinib-induced skin toxicities in epidermal growth factor receptor-mutated non-small-cell lung cancer : A multicenter, Phase II trial

enthalten in: Cancer medicine | 2023

von Iwasaku, M. | Uchino, J. | Chibana, K. | +16

2

A Phase II Trial on Osimertinib as a First-Line Treatment for EGFR Mutation-Positive Advanced NSCLC in Elderly Patients : The SPIRAL-0 Study

enthalten in: The oncologist | 2022

von Chihara, Y. | Takeda, T. | Goto, Y. | +20

ErratumIn: Oncologist. 2024 Mar 18;:. - PMID 38498842

3

Inhibition of c-Jun N-terminal kinase signaling increased apoptosis and prevented the emergence of ALK-TKI-tolerant cells in ALK-rearranged non-small cell lung cancer

enthalten in: Cancer letters | 2021

von Tanimura, K. | Yamada, T. | Horinaka, M. | +13

4

ONO-7475, a Novel AXL Inhibitor, Suppresses the Adaptive Resistance to Initial EGFR-TKI Treatment in EGFR-Mutated Non-Small Cell Lung Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2020

von Okura, N. | Nishioka, N. | Yamada, T. | +19

5

Prognostic impact of pleural effusion in EGFR-mutant non-small cell lung cancer patients without brain metastasis

enthalten in: Thoracic cancer | 2019

von Yoshimura, A. | Yamada, T. | Tsuji, T. | +7

6

AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells

enthalten in: Nature communications | 2019

von Taniguchi, H. | Yamada, T. | Wang, R. | +21

7

A phase II study of afatinib treatment for elderly patients with previously untreated advanced non-small-cell lung cancer harboring EGFR mutations

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2018

von Imai, H. | Kaira, K. | Suzuki, K. | +11

8

The impact of the tumor shrinkage by initial EGFR inhibitors according to the detection of EGFR-T790M mutation in patients with non-small cell lung cancer harboring EGFR mutations

enthalten in: BMC cancer | 2018

von Yoshimura, A. | Yamada, T. | Okura, N. | +11

9

An observational study of the epidermal growth factor receptor-tyrosine kinase inhibitor resistance mechanism in epidermal growth factor receptor gene mutation-positive non-small cell lung cancer

enthalten in: Medicine | 2018

von Yoshimura, A. | Uchino, J. | Tanimura, K. | +12

10

Treatment rationale and design of the SPIRAL study : A phase II trial of osimertinib in elderly epidermal growth factor receptor T790M-positive nonsmall-cell lung cancer patients who progressed during prior EGFR-TKI treatment

enthalten in: Medicine | 2018

von Uchino, J. | Nakao, A. | Tamiya, N. | +5